welcome
Reuters

Reuters

Health

Health

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

Reuters
Summary
Nutrition label

79% Informative

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine.

The review is part of a push to examine spending on messenger RNA -based vaccines.

Shares of vaccine maker fell 5.5% in after-market trading.

VR Score

90

Informative language

97

Neutral language

42

Article tone

formal

Language

English

Language complexity

55

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links